Lizinopril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lizinopril

Lisinopril is a prescription-only medication administered as an oral Tablet that functions as a powerful Angiotensin-Converting Enzyme Inhibitor (ACE Inhibitor). This drug is a synthetic compound designed to manage pressure within the circulatory system by targeting a critical hormonal pathway.


Quick Facts

Property Description
Active Ingredient Lisinopril
Form Oral Tablet
Pharmacological Class ACE Inhibitor (Angiotensin-Converting Enzyme Inhibitor)
Origin Synthetic compound (Dipeptide Derivative)
Type Single-ingredient preparation (Monotherapy)

Lisinopril: Definition and Pharmacological Class

The active component, Lisinopril, defines the medicine's pharmacological class as an ACE Inhibitor. This classification signifies that its mechanism involves blocking the enzyme responsible for generating a potent chemical that constricts blood vessels. The medication provides sustained efficacy in reducing systemic vascular resistance. Chemically, Lisinopril is a manufactured substance, specifically a Dipeptide known as a Lysine-Proline Derivative, confirming its origin as a synthetic compound. Lisinopril is often recognized by its former, popular trade names such as Zestril or Prinivil.


General Purpose: Promoting Vasodilation

The general purpose of an ACE Inhibitor is to lower blood pressure by promoting systemic Vasodilation—the widening of blood vessels. By inhibiting the enzyme, the drug facilitates this widening, which directly reduces the total peripheral resistance encountered by the flowing blood. This core antihypertensive effect is instrumental in helping the circulatory system operate under less strain, which is a typical, neutral use scenario for the drug class. Lisinopril is the sole active ingredient in this medication, presented as a standardized oral Tablet to ensure reliable, predictable dosing for its sustained, long-acting effect.

What side effects are possible with Lizinopril?

Possible Side Effects and Safety Information

The safety profile for Lisinopril, an Angiotensin-Converting Enzyme (ACE) Inhibitor, is defined by adverse reactions classified according to their frequency in regulatory documents.


Classification of Adverse Reactions

Adverse reactions span several System-Organ Classes (SOCs), including effects on the nervous, cardiovascular, and respiratory systems. Reactions are grouped by frequency as typically defined in European regulatory sources:

  • Common Reactions (occurring in 1 out of 100 to 1 out of 10 people): These include headache, dizziness, and a dry, persistent cough, which is a recognized class-effect of ACE Inhibitors. Other common reports include symptomatic hypotension (low blood pressure) and diarrhea.
  • Uncommon/Rare Reactions (occurring in fewer than 1 out of 100 people): Less frequent reactions include palpitations, vertigo, rash, and the development of elevations in blood urea nitrogen and serum creatinine, which indicate effects on renal function.

Serious Safety Concerns and Constraints

Official labeling highlights several serious adverse reactions and population-specific constraints:

  • Serious Adverse Reactions: The most critical documented risk is Angioedema, a rare but severe swelling of the face, lips, tongue, or larynx that can affect the airway. Other serious concerns include Acute Renal Failure and rare cases of Hepatic Failure.
  • Population Constraints: The drug is contraindicated for use during the second and third trimesters of pregnancy due to the high risk of fetal toxicity. The risk of Angioedema is also noted to be higher in Black patients. Furthermore, symptomatic hypotension is most likely to occur following the initial dose or upon a dose increase.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation states that the primary clinical sign of Lisinopril overdose is profound hypotension, which is an excessive reduction of blood pressure. Overdose may escalate to severe, life-threatening outcomes, including circulatory shock and Acute Renal Failure. Other documented manifestations include bradycardia (slowed heart rate) and the metabolic disturbance hyperkalemia (increased serum potassium), along with elevated serum creatinine and blood urea nitrogen (BUN) levels.

Required Emergency Actions

If an overdose is suspected, official guidance mandates that individuals seek immediate medical attention. For severe symptoms, such as collapse or seizure, emergency services must be contacted promptly. Management is strictly symptomatic and supportive treatment; the regulatory label explicitly states that no specific antidote is known for Lisinopril overdose. Treatment protocols may involve intravenous fluid infusion to manage hypotension. Lisinopril is dialyzable, meaning hemodialysis may be utilized to aid drug removal. Patients require intensive monitoring of blood pressure, renal function, and serum electrolytes.

Therapeutic Uses of Lizinopril

Lisinopril is commonly used to help with a range of health domains marked by increased physiological stress.


Managing High Blood Pressure (Hypertension)

Lisinopril is applied in areas where short-term symptom management is appropriate for symptoms related to heightened physiological activity. It helps address symptom clusters that may become intense or disruptive and assists with maintaining functional stability when symptoms interfere with daily comfort. This supports general well-being during symptomatic phases.

“This application of support is relevant in contexts marked by increased discomfort or tension.”

The primary domains where Lisinopril is considered relevant include conditions characterized by periods of heightened symptoms, conditions involving inflammatory or irritative processes, and scenarios where functional stability becomes affected.

Symptomatic Support Focus: Relief for Noticeable Strain Lisinopril may assist with managing groups of symptoms that create noticeable physiological strain, helping patients cope more steadily.


Supporting Function in Heart Failure

Lisinopril is applied in contexts where additional symptomatic support is needed for conditions characterized by periods of heightened symptoms, such as symptoms that create noticeable physiological strain. It contributes to easing the overall symptom load and supports the patient during difficult episodes by easing distress, which contributes to improved comfort when groups of symptoms create noticeable functional strain.


Offering Cardioprotective Support following Acute Episodes

Lisinopril is relevant in contexts marked by increased discomfort or tension following certain episodes marked by temporary physiological imbalance. It is commonly used to help with acute or disruptive episodes where short-term symptomatic assistance may be needed. This provides support that helps maintain a sense of stability during phases when the patient is experiencing heightened symptoms.

Regulatory References

  1. Lisinopril: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Scope

Classification Population or Condition
Allowed Adult patients for approved indications (Hypertension, Heart Failure, Post-MI).
Allowed (Restricted) Pediatric patients aged 6 to 16 years for hypertension, provided kidney function is adequate (GFR 30 mL/min/1.73 m^2).
Not Recommended Children under 6 years of age (safety/efficacy not established).
Contraindicated Pregnancy (2nd and 3rd trimesters), history of angioedema related to any ACE inhibitor, and hereditary angioedema.
Contraindicated Patients taking a Neprilysin Inhibitor (must discontinue for 36 hours before use).
Contraindicated Patients with diabetes or renal impairment taking the Renin inhibitor Aliskiren.

Age-related eligibility rules: Use is established in adults and in children 6 years and older for hypertension only. Older adults generally show similar efficacy but require caution due to the higher likelihood of age-related kidney function impairment.

Condition-specific eligibility rules: Severe renal impairment requires caution and adjustment. Lisinopril is generally avoided in patients with acute myocardial infarction who are hemodynamically unstable (systolic blood pressure leq 100 mmHg). The official status for use during lactation is generally not recommended.

Eligibility Classifications (High-Level)

Official regulatory documents classify patient use status as Contraindicated (absolute prohibition), Not Recommended (safety not established/risk concern), or Established (approved use). These classifications define who is eligible based on history, co-administered drugs, age, and organ function, such as renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions with Lisinopril as documented in official government regulatory information.

Contraindicated and Restricted Combinations

Classification Interacting Substance Regulatory Constraint
Contraindicated Sacubitril/Valsartan Prohibited due to angioedema risk. Requires a minimum 36-hour separation window.
Contraindicated Aliskiren Prohibited in patients with Diabetes Mellitus or Renal Impairment (GFR < 60 mL/min/1.73 m²).
Not Recommended Potassium-Sparing Diuretics (e.g., Spironolactone, Triamterene) High risk of hyperkalaemia (high potassium levels).

Documented Interaction Outcomes

  • Potassium-Elevating Agents: Co-administration with Potassium Supplements, salt substitutes containing potassium, or other agents like Heparin increases the risk of severe hyperkalaemia.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Concurrent use may cause a loss of antihypertensive effect and an increased risk of worsening renal function, particularly in the elderly or those with existing kidney compromise.
  • Lithium: Lisinopril reduces the renal clearance of Lithium, leading to elevated serum Lithium concentrations and the potential for toxicity.
  • mTOR Inhibitors: Use with agents like Sirolimus increases the documented risk of angioedema.
  • Antidiabetic Agents: Concomitant use with insulin or oral hypoglycemic agents may increase the risk of hypoglycemia (low blood sugar).

Administration and Clearance

  • Lisinopril absorption is documented as not influenced by food intake.
  • The drug is non-metabolized and excreted unchanged, making classic CYP-enzyme interactions irrelevant to its clearance profile.

Mechanism of Action

Lisinopril functions as a competitive inhibitor of the angiotensin-converting enzyme (ACE), a zinc-containing metalloprotease predominantly located on the luminal surface of endothelial cells. The primary biological target is the ACE enzyme, where Lisinopril binds to the active site, blocking its catalytic function.

This interaction type interrupts two major molecular and intracellular pathways. Firstly, it prevents ACE from converting inactive angiotensin I into the potent vasoconstrictor angiotensin II. Secondly, it inhibits the degradation of the vasodilator peptide bradykinin by ACE.

The downstream cascade of reduced angiotensin II leads to decreased stimulation of AT1 receptors and, consequently, reduced aldosterone secretion from the adrenal cortex. The resulting increase in systemic bradykinin and decrease in AT1 receptor activity contribute to the system-level physiological consequences: a reduction in total peripheral vascular resistance and a decrease in renal sodium and water retention.

Dosage and Administration Information

How to Use Lisinopril: Official Administration Guidelines

Lisinopril is a prescription-only medication administered via the oral route as a tablet or an oral solution. The official instructions for its use standardize dosing, frequency, and administration conditions across all approved applications.


Standard Dosing and Schedule

Lisinopril is typically taken once daily at approximately the same time each day, and its absorption is not affected by food, meaning it can be taken with or without meals.

Indication Initial Adult Dose (Once Daily) Maintenance Dose (Usual Range) Maximum Dose
Hypertension 10 mg (or 5 mg if on a diuretic) 20 mg to 40 mg 80 mg
Heart Failure 2.5 mg to 5 mg Up to 40 mg 40 mg
Acute MI (First 24-48 hrs) 5 mg (followed by 5 mg at 24h, 10 mg at 48h) 10 mg once daily (for ge 6 weeks) 10 mg

Population-Specific Use and Adjustments

Dosage adjustments are specifically required for certain populations, particularly those with reduced kidney function. For adult patients with renal impairment (Creatinine Clearance 10 to 30 mL/min), the usual starting dose is halved (e.g., 5 mg for hypertension). For severe impairment or patients on hemodialysis, starting at 2.5 mg once daily is recommended.

In pediatric patients (aged ge 6 years) with adequate kidney function, the initial dose is weight-based (0.07 mg/kg up to 5 mg total) and is adjusted according to the patient's response. Dosage increases for adults typically occur at intervals of two to four weeks.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lisinopril


Evidence for Use in Managing High Blood Pressure (Hypertension)

Research exploring the use of Lisinopril for systemic high blood pressure has relied on large-scale Randomized Controlled Trials (RCTs) and comparative studies. These studies were conducted during periods of increased symptom activity and compared the medicine to inactive substances (placebo) and other classes of blood pressure medications. The main outcomes research examined included changes measured in Systolic and Diastolic Blood Pressure (BP). Studies also monitored the incidence of major cardiovascular events such as heart attack and stroke. The studies report on patterns of measured changes in blood pressure, contributing to the broader evidence landscape for the study of high blood pressure.


Evidence for Use as Adjunctive Therapy in Heart Failure

For heart failure, research explored the use of Lisinopril as an adjunctive treatment, meaning it was studied alongside other commonly used therapies. These were large, international studies focusing on adults with symptomatic heart failure where the heart's pumping function was reduced (systolic dysfunction). Research monitored outcomes related to functional imbalance, including All-cause Mortality and the frequency of Hospitalization for heart failure, as well as outcomes reflecting daily functioning or activity level. Studies report on patterns of observed mortality rates and hospitalization events in the populations studied when this medicine was examined with the standard regimen.


What is Still Uncertain About Lisinopril Research

Certainty remains low for some areas, and evidence is limited for certain groups. Data for certain groups remain insufficient; for example, there is limited information regarding the use of Lisinopril in very young children (under age 6) with hypertension. Comparative evidence is lacking for how Lisinopril performs against every other ACE inhibitor in all approved clinical situations. Long-term effects are not fully established for all populations. Findings describe group patterns, not personal outcomes, and research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Lizinopril (FAQ)

Q: Why is the persistent dry cough a common side effect of Lizinopril?

Official product information describes the dry, persistent cough as a common side effect and a recognized class-effect of medicines like Lisinopril (ACE inhibitors). This reaction is thought to occur because the medicine interferes with the natural process that breaks down certain chemicals in the body, leading to their accumulation in the respiratory system.


Q: How long does the cough side effect usually last after beginning Lizinopril therapy?

According to government health information, if the persistent cough is determined to be caused by Lisinopril, it may take a significant amount of time to resolve. Resolution can take up to a month even after the use of the medicine has been discontinued.


Q: How quickly should someone expect Lisinopril to start lowering blood pressure?

Official studies of Lisinopril indicate that blood pressure-lowering activity is generally observed starting about one hour after an oral dose. The greatest reduction in blood pressure typically occurs around six hours after taking the medicine.


Q: What is angioedema, and why is it a severe potential side effect of Lizinopril?

Angioedema is classified as a rare but severe swelling of the face, lips, tongue, and throat that poses a risk to the airway. Regulatory information suggests this occurs because the drug interferes with systems responsible for breaking down certain chemical substances, potentially triggering the swelling.


Q: Is it normal to feel dizzy or lightheaded shortly after starting Lisinopril?

Dizziness and lightheadedness are common side effects listed in official documents. This sensation is most likely to occur following the initial dose or when moving suddenly from a sitting or lying down position, which is a known effect of blood pressure reduction.


Q: Is a sudden feeling of being very tired or weak a potential sign of a severe reaction to Lizinopril?

While fatigue and tiredness are commonly reported adverse reactions, severe or unusual weakness can sometimes indicate a more serious, rare reaction. Official information warns that if severe tiredness is combined with symptoms like fever, sore throat, or yellowing of the skin (jaundice), medical attention may be required.


Q: What is the meaning of the Black Box Warning associated with Lizinopril?

The official Boxed Warning, sometimes referred to as a Black Box Warning, is the strictest warning required by the FDA. For Lisinopril, this warning alerts patients that use during the second and third trimesters of pregnancy can cause severe injury and even death to the developing fetus.


Q: Why is a person with bilateral renal artery stenosis generally advised not to use Lizinopril?

Regulatory documents advise caution regarding the use of Lisinopril in patients with pre-existing kidney conditions. For individuals with bilateral renal artery stenosis (narrowing of the kidney arteries), the medicine is generally avoided due to a specific increased risk of worsening kidney function.


Q: What is the evidence regarding the long-term safety of Lizinopril use?

Research evidence indicates that the blood pressure-lowering effects are generally sustained when Lisinopril is used as a long-term therapy. However, official reports also state that long-term safety profiles are not yet fully established for all patient populations.


Q: Does Lizinopril interact with common antidiabetic medications or insulin?

Yes, according to official drug interaction guidance, Lisinopril can interact with insulin and other oral medicines used to manage blood sugar. This combination may increase the risk of low blood sugar (hypoglycemia).


Q: What are the key differences between Lisinopril and an ARB drug like Losartan?

Official regulatory mechanisms describe Lisinopril as an ACE inhibitor, meaning it blocks the enzyme that creates the chemical signal for blood vessel constriction. Conversely, ARB drugs, such as Losartan, work by blocking the specific receptors on the blood vessels that this chemical signal needs to activate.


Q: Is a severe headache a common or serious side effect of Lizinopril?

Headache is classified in official documents as a common adverse reaction associated with Lisinopril. While it is generally not classified as a serious side effect, further guidance may be warranted if the headaches are severe or continue for a long period.


Q: How does Lisinopril affect the heart's workload? (High-level explanation)

Official pharmacological descriptions state that Lisinopril causes the widening of blood vessels (vasodilation). This effect reduces the overall resistance in the circulatory system, which is intended to decrease the amount of effort the heart must exert to pump blood.


Q: What is the typical time frame for Lisinopril to reach its full effect on blood pressure?

Clinical studies indicate that while the initial blood pressure reduction begins relatively quickly, the medicine may take several weeks to reach its full therapeutic potential. The full, stable clinical effect on blood pressure is typically achieved over two to four weeks of consistent use.


Q: What is the main difference between Lizinopril and blood pressure pills that are not ACE inhibitors?

Lisinopril belongs to the class of ACE inhibitors, which work by preventing an enzyme from creating a potent chemical that constricts blood vessels. Other classes of medicines for high blood pressure use entirely different mechanisms, such as relaxing the blood vessel walls directly, blocking receptors, or increasing the removal of fluid and salt.


Q: Does Lisinopril help with conditions other than high blood pressure, like heart failure or after a heart attack?

Yes, the official indications for Lisinopril include more than just the treatment of high blood pressure. Regulatory approvals also include its use as an add-on therapy for patients with heart failure and for reducing the risk of death following a recent acute heart attack.


Q: What happens to blood pressure if Lizinopril is stopped suddenly?

Clinical studies indicate that abruptly stopping Lisinopril is not typically associated with a rapid or significant rebound increase in blood pressure immediately after cessation. However, because the medicine is treating a chronic condition, stopping treatment entirely will likely lead to blood pressure rising again over time.


Q: Is there any known risk of Lizinopril causing sexual side effects or changes in libido?

Official regulatory data from clinical trials indicates that side effects related to sexual function, such as decreased libido and erectile dysfunction (impotence), have been reported. These effects were noted to occur in a small percentage of the patient population studied.


Q: Why is fatigue or tiredness often reported as a side effect?

Fatigue and general tiredness are classified among the common adverse reactions documented in clinical trial data for Lisinopril. While the precise physiological cause of this feeling is not fully established, it is a frequently reported experience among patients.


Q: Can Lizinopril cause symptoms like a sore throat or fever?

Official safety information indicates that in rare cases, symptoms like sore throat and fever can occur. These symptoms can be associated with a serious underlying blood disorder, such as a low white blood cell count, which has been rarely linked to Lisinopril use.


Q: Does the research show Lisinopril is used in pediatric populations (children)?

Regulatory approvals indicate that Lisinopril is approved for the treatment of high blood pressure in children aged 6 years and older. However, the medicine is not recommended for use in children under the age of 6.


Q: Is Lisinopril used primarily to treat heart failure, high blood pressure, or both?

According to the official regulatory indications, Lisinopril is approved for use in treating both high blood pressure (hypertension) and as an adjunct (add-on) therapy for patients with heart failure.


Q: Can Lizinopril cause an increase in blood sugar levels?

Lisinopril is not generally known to cause an increase in blood sugar levels. In fact, official interaction information indicates that when used with antidiabetic medications, there may be an increased risk of low blood sugar (hypoglycemia).


Q: Do studies indicate that Lisinopril can cause weight gain or fluid retention?

There is no regulatory documentation indicating that Lisinopril causes measurable weight gain. However, the medicine can sometimes be associated with swelling in the feet and ankles, and sudden, unexplained weight gain can be a sign of a serious adverse event like worsening heart failure or angioedema.


Q: Why might a doctor temporarily advise stopping Lisinopril before a planned surgery or anesthesia?

Official information indicates that healthcare providers may recommend informing the surgical team about Lisinopril use before major surgery or general anesthesia. This is due to the potential for ACE inhibitors to increase the risk of a severe drop in blood pressure (hypotension) during the medical procedure.


Q: Can taking certain herbal supplements interfere with how Lisinopril works?

Yes, official drug guides caution that some herbal supplements can interfere with Lisinopril. Specifically, supplements that act like diuretics or contain high levels of potassium may increase the risk of excessively low blood pressure or dangerously high potassium levels in the blood.


Q: What are the signs that Lisinopril may be affecting the liver?

Regulatory safety information warns of rare but serious liver problems associated with Lisinopril. Potential signs include yellowing of the skin or the whites of the eyes (jaundice), dark urine, and unusual weakness.


Q: Is a metallic or changed sense of taste a possible side effect of Lisinopril?

Yes, changes or disturbances in the sense of taste have been documented in official product information as a possible side effect. While not classified among the most common adverse reactions, its occurrence has been noted.


Q: Is it true that Lisinopril may not work as effectively for blood pressure control in Black patients?

Regulatory clinical studies indicate that Black patients treated with Lisinopril alone showed a smaller average blood pressure response compared to non-Black patients. However, this difference is often eliminated when Lisinopril is used in combination with a diuretic.


Q: Are there any restrictions on alcohol consumption while taking Lisinopril?

Yes, official guidance advises caution regarding alcohol consumption. Alcohol can enhance the blood pressure-lowering effect of Lisinopril, which may lead to excessive lightheadedness, dizziness, or fainting.


Q: Can the use of Lizinopril lead to low white blood cell counts or other blood cell problems?

In rare instances, Lisinopril has been associated with serious effects on the blood components. This includes the possibility of a reduction in white blood cell counts (known as leukopenia or neutropenia) or other bone marrow disorders.


Q: How does Lisinopril compare to other common ACE inhibitor medicines like Ramipril or Enalapril?

Lisinopril, Ramipril, and Enalapril all belong to the same pharmacological class, ACE inhibitors, and share the same core mechanism of action. Official research summaries state that comprehensive comparative efficacy data is not available across all approved clinical situations.


Q: Are there any known foods or beverages, besides alcohol, that should be avoided with Lisinopril?

Foods and beverages that are moderately high or high in potassium should be consumed with caution, and potassium-containing salt substitutes should be avoided, due to the risk of dangerously high potassium levels in the blood.

How should Lizinopril be stored and disposed of?

How to Store and Dispose of Lisinopril

Lisinopril tablets must be stored according to regulatory requirements to preserve product integrity and safety.

Storage Conditions

Requirement Official Condition
Temperature Store at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F).
Protection Protect from moisture, excessive heat, and freezing (Do not freeze).
Container Keep the product in a tight container, often the original package, for maximum protection.
Child Safety Store strictly out of the sight and reach of children.

Disposal Instructions

Any unused or expired Lisinopril must be handled safely. Disposal should be carried out in accordance with local requirements for pharmaceutical waste. The product is not typically recommended for flushing down the toilet; safe methods include authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lizinopril found in:

A-Z Index: